NEW YORK– Today, Happify Health, the Intelligent Healing Company, announced findings from a real-world data analysis exploring the impact of Happify for users with self-reported psoriasis. Psoriasis affects 125 million people worldwide, making it a “serious global problem” according to the World Health Organization. In the U.S., 7.5 million adults over age 20 have the condition, costing the U.S. healthcare system approximately $112 billion each year1.
Details of Happify Health’s real-world data analysis are available online.
The analysis found Happify Health’s solution was associated with a 27% improvement in subjective well-being and a 27% decrease in anxiety symptoms, which have been identified as a trigger for psoriasis symptoms4. Greater improvements were found among those who engaged with Happify at recommended levels.
“Psoriasis may be a physical condition, but because scaling is so apparent, and the perceived stigma often leads to feelings of embarrassment, shame, low self-esteem, and self-consciousness, it’s no surprise that people experience anxiety and impaired well-being,” said Murray Zucker, MD, Chief Medical Officer at Happify Health. “This new analysis is important because it suggests that digital interventions like Happify Health can have a significant—and positive impact—on those suffering with psoriasis and should be a part of any psoriasis care plan.”
Happify researchers analyzed data from 219 Happify users with self-reported psoriasis and examined changes in anxiety symptoms and well-being among the participants based on their usage, as measured by their Happify Score5, a proprietary, clinically-validated, behavioral health assessment.
